Document Detail

Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease.
MedLine Citation:
PMID:  20976765     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Amyloid-β(Aβ) aggregates are presumed to be found in the brain at an early stage of Alzheimer's disease (AD) but have seldom been assessed by brain biopsy during life in often elderly patients. METHODS: Between 1991 and 2006 we evaluated 468 patients with suspected normal pressure hydrocephalus with intraventricular pressure monitoring and a right frontal cortical biopsy sample immunostained for Aβ and hyperphosphorylated tau (HPτ). Adequate samples and the clinical follow-up data until death or the end of 2008, available in 433 cases, were reviewed for the clinical signs of dementia, including AD. Logistic regression analysis was used to analyze whether Aβ and/or HPτ in the biopsy samples obtained during life predicted development of cognitive impairment, in particular, AD. RESULTS: Of the 433 frontal cortical samples, 42 (10%) displayed both Aβ and HPτ, 144 (33%) Aβ only, and 247 (57%) neither Aβ nor HPτ. In a median follow-up time of 4.4 years, 94 patients (22%) developed clinical AD. The presence of both Aβ and HPτ was strongly associated (odds ratio [OR], 68.2; 95% confidence interval [CI], 22.1-210) and Aβ alone significantly associated (OR, 10.8; 95% CI, 4.9-23.8) with the clinical diagnosis of AD. INTERPRETATION: This is the largest follow-up study of patients assessed for the presence of Aβ and HPτ in frontal cortical brain biopsy samples. 1) The presence of Aβ and HPτ spoke strongly for the presence or later development of clinical AD; 2) Aβ alone was suggestive of AD; and 3) the absence of Aβ and HPτ spoke against a later clinical diagnosis of AD.
Ville Leinonen; Anne M Koivisto; Sakari Savolainen; Jaana Rummukainen; Juuso N Tamminen; Tomi Tillgren; Sannakaisa Vainikka; Okko T Pyykkö; Juhani Mölsä; Mikael Fraunberg; Tuula Pirttilä; Juha E Jääskeläinen; Hilkka Soininen; Jaakko Rinne; Irina Alafuzoff
Related Documents :
20440655 - Automated mr morphometry to predict alzheimer's disease in mild cognitive impairment.
1202165 - Use of computerized tomography in senile dementia.
9926865 - Severe pathological changes of parabrachial nucleus in alzheimer's disease.
12784035 - Factor structure of a modified version of the wisconsin card sorting test: an analysis ...
10535545 - Microvascular anastomosis in oral reconstructive surgery: a comparative study of recipi...
1789215 - Changes in urate metabolism after castration of patients suffering from carcinoma of th...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Annals of neurology     Volume:  68     ISSN:  1531-8249     ISO Abbreviation:  Ann. Neurol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-26     Completed Date:  2010-11-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7707449     Medline TA:  Ann Neurol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  446-53     Citation Subset:  IM    
Department of Neurosurgery, Kuopio University Hospital, Kuopio, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Alzheimer Disease / complications,  pathology*
Amyloid beta-Protein / metabolism*
Biopsy / methods
Cerebral Cortex / metabolism*
Cognition Disorders / etiology
Logistic Models
Longitudinal Studies
Middle Aged
Psychiatric Status Rating Scales
Retrospective Studies
Sensitivity and Specificity
tau Proteins / metabolism*
Reg. No./Substance:
0/Amyloid beta-Protein; 0/tau Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mesial temporal lobe epilepsy: How do we improve surgical outcome?
Next Document:  Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.